COMMENTCell therapies might revolutionise treatment for multiple sclerosis patientsDownturn for top biopharma companies as Covid-19 vaccine demand falls in Q3Inflation threatens supply of life-saving generics to EuropeData is the key to a safer and more controlled pharmaceutical cold-chainR&DHigh hopes for mRNA anti-cancer vaccines with early successesA combination of Moderna’s mRNA vaccine and Merck’s Keytruda has shown encouraging signals in early data, say GlobalData analysts. insightEurope reports the highest prevalence of chronic coughcommentCould vaccine hesitancy impact hearing disorders?Cell therapies might revolutionise treatment for multiple sclerosis patientsDownturn for top biopharma companies as Covid-19 vaccine demand falls in Q3Inflation threatens supply of life-saving generics to EuropeData is the key to a safer and more controlled pharmaceutical cold-chain02/24/2024 13:23:12
Cell therapies might revolutionise treatment for multiple sclerosis patients
Downturn for top biopharma companies as Covid-19 vaccine demand falls in Q3
Inflation threatens supply of life-saving generics to Europe
Data is the key to a safer and more controlled pharmaceutical cold-chain